Physician profile
Ravi D Chauhan
NPI 1588621254
$181,827.74
in general payments reported to CMS, 2019-2025
49 companies · $140K in 2025
The $140K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,557 · 2020: $677 · 2021: $505 · 2022: $498 · 2023: $1,106 · 2024: $34K · 2025: $140K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $108K · Travel and Lodging: $24K · Consulting Fee: $22K · Food and Beverage: $13K · Honoraria: $3,825 · Education: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $108,271.00 |
| Travel and Lodging | $24,425.91 |
| Consulting Fee | $22,040.00 |
| Food and Beverage | $13,028.69 |
| Honoraria | $3,825.00 |
| Education | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $124,281.89 | 2019-2025 | Adstiladrin, Menopur |
| Merck Sharp & Dohme LLC | $12,002.07 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Intuitive Surgical, INC. | $10,075.73 | 2019-2025 | Da Vinci Surgical System |
| Janssen Biotech, INC. | $7,987.93 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Urogen Pharma, INC. | $4,709.73 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $3,170.78 | 2019-2025 | Padcev, Myrbetriq |
| Immunitybio, INC. | $3,133.23 | 2025 | |
| Teleflex LLC | $2,395.93 | 2024-2025 | Barrigel, Urolift |
| Janssen Scientific Affairs, LLC | $1,977.00 | 2024-2025 | Erleada, Akeega |
| Telix Pharmaceuticals | $1,911.72 | 2024-2025 | Illuccix |
| Pfizer INC. | $1,761.06 | 2024-2025 | |
| Angiodynamics, INC. | $1,390.06 | 2024-2025 | Nanoknife |
| Astrazeneca Pharmaceuticals Lp | $1,383.11 | 2020-2024 | Imfinzi |
| Neotract INC. | $939.42 | 2019 | |
| Uromedica, Incorporated | $709.20 | 2019 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $640.61 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $535.36 | 2019-2025 | Provenge |
| Blue Earth Diagnostics | $349.86 | 2021-2024 | |
| Abbvie INC. | $245.67 | 2021-2025 | Botox, Lupron Depot |
| Axonics, INC. | $217.94 | 2020-2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $193.98 | 2023-2025 | |
| Procept Biorobotics Corporation | $177.79 | 2024-2025 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $167.34 | 2022-2025 | Prolaris |
| Allergan, INC. | $140.38 | 2019-2020 | |
| Calyxo, INC. | $125.93 | 2025 | Cvac Aspiration System |
| Tolmar, INC. | $120.00 | 2023-2025 | Eligard, Jatenzo |
| Clarus Therapeutics INC. | $113.48 | 2020-2021 | |
| Amgen INC. | $95.78 | 2022 | |
| Coloplast Corp | $95.38 | 2019-2025 | |
| Myovant Sciences INC. | $86.29 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $80.17 | 2023-2025 | Trelstar |
| Urovant Sciences INC | $77.38 | 2022 | |
| Endo Pharmaceuticals INC. | $72.46 | 2020-2021 | |
| Halozyme INC | $66.33 | 2023 | |
| Laborie Medical Technologies Corp. | $55.81 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Valencia Technologies Corporation | $44.31 | 2025 | Ecoin Device Kit |
| Avadel Specialty Pharmaceuticals, LLC | $41.04 | 2019 | |
| Cardinal Health 108 LLC | $35.11 | 2025 | |
| Rochester Medical Corporation | $32.87 | 2019 | |
| Alnylam Pharmaceuticals INC. | $26.33 | 2022 | |
| Conmed Corporation | $25.25 | 2024 | Airseal |
| Medtronic, INC. | $24.12 | 2023 | Signia |
| Accord Healthcare, INC. | $19.56 | 2025 | |
| Antares Pharma, INC. | $19.28 | 2024 | Xyosted |
| Pacira Pharmaceuticals Incorporated | $16.60 | 2024 | Exparel |
| Tempus Ai, INC | $16.01 | 2024 | Xt Cdx |
| Sandoz INC. | $14.33 | 2025 | Wyost, Jubbonti |
| Cook Medical LLC | $13.46 | 2024 | Resonance |
| Boston Scientific Corporation | $12.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Chauhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.